新药物时代慢性淋巴细胞白血病的异基因造血干细胞移植:挑战、缺陷和优势

{"title":"新药物时代慢性淋巴细胞白血病的异基因造血干细胞移植:挑战、缺陷和优势","authors":"Cynthia L. Toze , Steven Huang","doi":"10.1016/j.onsig.2018.09.004","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":92564,"journal":{"name":"Oncology signaling","volume":"1 1","pages":"Pages 14-16"},"PeriodicalIF":0.0000,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.onsig.2018.09.004","citationCount":"0","resultStr":"{\"title\":\"Allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia in the era of novel agents: Challenges, pitfalls and strengths\",\"authors\":\"Cynthia L. Toze , Steven Huang\",\"doi\":\"10.1016/j.onsig.2018.09.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":92564,\"journal\":{\"name\":\"Oncology signaling\",\"volume\":\"1 1\",\"pages\":\"Pages 14-16\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.onsig.2018.09.004\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology signaling\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2542563318300226\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology signaling","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2542563318300226","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}